Sorin Group S.p.A. (SRN) Announces FDA Approval and U.S. Launch OF SMARTVIEW™ Remote Monitoring Solution for Patients With Implanted Cardiac Defibrillators
5/10/2013 11:31:17 AM
More...
|
Sorin Group S.p.A. (SRN) Announces Results for the First Quarter of 2013
4/29/2013 8:14:26 AM
More...
|
Sorin Group S.p.A. (SRN)'s Cardiac Resynchronization Device Wins Conditional FDA Approval
3/25/2013 8:56:13 AM
More...
|
Sorin Group S.p.A. (SRN) Receives Conditional FDA Approval to Conduct RESPOND CRT Clinical Trial Using Innovative Heart Failure Management Technology
3/20/2013 10:36:35 AM
More...
|
Sorin Group S.p.A. (SRN) Receives PMDA Approval for Mitroflow® Aortic Pericardial Heart Valve
12/4/2012 7:53:37 AM
More...
|
Sorin Group S.p.A. (SRN) Invests $5.4 Million in HighLife SAS for Mitral Valve Tech.
11/26/2012 8:58:34 AM
More...
|
Sorin Group S.p.A. (SRN) Acquires Catholic University of Leuven Spin-Off Neurotech
11/12/2012 8:04:06 AM
More...
|
Sorin Group S.p.A. (SRN) Announces U.S. Launch of New Heart Device for Simultaneous Implantation of an Aortic Tissue Valve and Ascending Aorta
11/6/2012 8:56:03 AM
More...
|
Sorin Group S.p.A. (SRN) Announes 2012 Third Quarter Results
11/1/2012 8:36:00 AM
More...
|
Sorin Group S.p.A. (SRN) Announces CE Mark Approval of Extended Indications and 2nd Generation Accessories for Perceval™ S
9/18/2012 7:19:41 AM
More...
|
|